Compare Applied Digital Corporation (APLD) vs AstraZeneca plc (AZN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applied Digital Corporation vs AstraZeneca plc — how do they compare? Applied Digital Corporation trades at $31.94 (market cap $8.55B), while AstraZeneca plc trades at $157.96 (market cap $248.14B). The key difference: AstraZeneca plc is far larger — about 29× Applied Digital Corporation's market cap, and AstraZeneca plc pays a 2.01% dividend while Applied Digital Corporation pays none. Which is the better fit depends on your goals.
| APLD | AZN | |
|---|---|---|
Market Cap | $8.55B | $248.14B |
Sector | Technology | Health |
52-Week High | $49.65 | $209.48 |
52-Week Low | $13.89 | $147.06 |
Enterprise Value | $12.06B | $275.41B |
Dividend Yield | — | 2.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Applied Digital (APLD) trades at $29.06, down 0.55% on the day, with a bearish technical signal and recent earnings misses. The company reported a net loss of $231.07 million in 2025 despite revenue growth, while analyst consensus remains strongly bullish with a $72.36 price target. Recent news highlights significant AI infrastructure contracts and insider selling activity.
Outlook hinges on execution of its $36 billion AI infrastructure pipeline, but risks include high cash burn, negative margins, and rising debt. The stock offers high growth potential if operational targets are met, yet financial sustainability concerns warrant caution for investors amid volatile sentiment.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applied Digital Corporation
Applied Digital provides high-performance computing (HPC) infrastructure and cloud services. It designs and operates data centers tailored for AI, machine learning, and other intensive digital workloads across North America.
Read more on APLD →About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →
